TITLE

IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease

AUTHOR(S)
Kobayashi, T; Okamoto, S; Hisamatsu, T; Kamada, N; Chinen, H; Saito, R; Kitazume, M T; Nakazawa, A; Sugita, A; Koganei, K; Isobe, K; Hibi, T
PUB. DATE
December 2008
SOURCE
Gut;Dec2008, Vol. 57 Issue 12, p1682
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: A novel T helper (Th) cell lineage, Th17, that exclusively produces the proinflammatory cytokine interleukin 17 )1L17) has been reported to play important roles in various inflammatory diseases. 1L23 is also focused upon for its potential to promote 1h17. Here, the roles of the lL23/IL1 7 axis in inflammatory bowel diseases such as ulcerative colitis (UC) and Crohn's disease (CD) were investigated. Methods: Mucosal samples were obtained from surgically resected specimens (controls, n = 12; UC, n = 17; CD, n = 22). 1L17 production by isolated peripheral blood (PB) and lamina propria )LP) CD4~ cells was examined. Quantitative PCR amplification was performed to determine the mRNA expression levels of 1L17, interferon y (IFN'y), 1L23 receptor )1L23R) and retinoic acid-related orphan receptor -y (RORC) in LP CD4~ cells, and 1L12 family members, such as ILl 2p40, ILl 2p35 and lL23p19, in whole mucosal specimens. The effects of exogenous 1L23 on ILl 7 production by LP CD4~ cells were also examined. Results: 1L17 production was higher in LP CD4~ cells than in PB. Significant 1L17 mRNA upregulation in LP CD4~ cells was found in UC, while IFN-y was increased in CD. IL23R and RORC were upregulated in LP CD4~ cells isolated from both UC and CD. 1L17 production was significantly increased by 1L23 in LP CD4~ cells from UC but not CD. Upregulated lL23p19 mRNA expression was correlated with 1L17 in UC and IFN-y in CD. Conclusions: lL23 may play important roles in controlling the differential Thl/Thl 7 balance in both UC and CD, althouqh Th17 cells may exist in both diseases.
ACCESSION #
35718730

 

Related Articles

  • Mucosal cytokine network in inflammatory bowel disease. Andoh, Akira; Yagi, Yuhki; Shioya, Makoto; Nishida, Atsushi; Tsujikawa, Tomoyuki; Fujiyama, Yoshihide; Costa, Francesco; Das, Kiron M. // World Journal of Gastroenterology;9/7/2008, Vol. 14 Issue 33, p5154 

    Inflammatory bowel disease (IBD), ulcerative colitis (UC) and Crohn's disease (CD) are characterized by ongoing mucosal inflammation in which dysfunction of the host immunologic response against dietary factors and commensal bacteria is involved. The chronic inflammatory process leads to...

  • Forms of IBD have distinctive features.  // New Zealand Doctor;2/10/2010, p20 

    The article presents information on the forms of inflammatory bowel diseases and their features. It notes that there is a difference between the inflammation of Crohn's disease and ulcerative colitis. Gross dilatation of the colon may occur in a person suffering from severe fulminant colitis...

  • Indeterminate colitis. Guindi, M.; Riddell, R. H. // Journal of Clinical Pathology;Dec2004, Vol. 57 Issue 12, p1233 

    Indeterminate colitis (IC) originally referred to those 10- 15% of cases of inflammatory bowel disease (IBD) in which there was difficulty distinguishing between ulcerative colitis (UC) and Crohn's disease (CD) in the colectomy specimen. However, IC is increasingly used when a definitive...

  • IL-23: a master regulator in Crohn disease. Neurath, Markus F. // Nature Medicine;Jan2007, Vol. 13 Issue 1, p26 

    The article focuses on the studies in pro-inflammatory cytokine interleukin (IL)-23. The common gastrointestinal diseases are the chronic inflammatory bowel diseases ulcerative colitis and Crohn's disease. The article suggests that studies should focus on the new IL-23 which performs a unique...

  • Evolving knowledge and therapy of inflammatory bowel disease. Korzenik, Joshua R.; Podolsky, Daniel K. // Nature Reviews Drug Discovery;Mar2006, Vol. 5 Issue 3, p197 

    With recent advances in the understanding of its pathophysiology, inflammatory bowel disease has become a very active area for the development of novel therapeutic agents. New targets for biologics include cytokines involved in T-cell activation, with antibodies directed against IL-12 and...

  • Inflammatory Bowel Disease with an Onset during Pregnancy. Akbar, Hisham O.; Fallatah, Hind I. // Internet Journal of Gastroenterology;2010, Vol. 9 Issue 1, p8 

    A 35-year-old Egyptian woman, was pregnant with twins and had gestational diabetes. She developed severe watery diarrhea at 32 week of gestation. This was thought to be due to infectious diarrhea, but she did not respond completely to the treatment with antibiotics. After extensive work up we...

  • COLON TARGETED DRUG DELIVERY SYSTEM: A REVIEW. Reddy, R. B. Desi; Malleswari, K.; Prasad, G.; Pavani, G. // International Journal of Pharmaceutical Sciences & Research;Jan2013, Vol. 4 Issue 1, p42 

    Day by day there are new developments in field of colon specific drug delivery system. Colonic drug delivery has gained increased importance not just for the delivery of the drugs for the treatment of local diseases associated with the colon like Crohn's disease, ulcerative colitis, etc. but...

  • Pitfalls in the Interpretation of Nonneoplastic Mucosal Biopsies in Inflammatory Bowel Disease. Yantiss, Rhonda K.; Odze, Robert D. // American Journal of Gastroenterology;Apr2007, Vol. 102 Issue 4, p890 

    This review provides a summary of common diagnostic problems encountered by both pathologists and gastroenterologists when evaluating patients with diarrhea and in whom inflammatory bowel disease (IBD) is suspected. The two most common forms of IBD, ulcerative colitis (UC) and Crohn's disease...

  • Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease. Andrisani, G.; Guidi, L.; Papa, A.; Armuzzi, A. // European Review for Medical & Pharmacological Sciences;2012, Vol. 16 Issue 7, p890 

    Inflammatory bowel disease, Crohn's disease and ulcerative colitis, are immune- mediated disorders of unknown etiology that primarily affect the gastrointestinal tract. In addition, other organ systems can be involved such as joint/bones, skin, eyes, hepatobiliary tract, lungs and kidney....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics